Related by context. All words. (Click for frequent words.) 76 AEG# 75 HCV protease inhibitor 73 PDE4 inhibitor 73 IAP inhibitor 73 CCX# 73 R#/MEM # 73 orally bioavailable 73 JAK inhibitor 73 pan HDAC inhibitor 72 proteasome inhibitor 72 protein kinase inhibitor 72 polymerase inhibitor 72 ALN TTR 72 oral prodrug 72 mertansine 72 protein tyrosine phosphatase 1B 72 orally administered inhibitor 72 TRO# 72 Aflibercept 72 anticancer compound 72 investigational humanized monoclonal antibody 72 ATL# [001] 72 RhuDex ® 72 KSP inhibitor 72 glucokinase activator 71 Omacetaxine 71 mitogen activated ERK kinase 71 JAK1 71 targeted radiotherapeutic 71 PSMA ADC 71 Phase IIb clinical trials 71 SAR# [002] 71 ALN PCS 71 Onconase 71 Aurora kinase 71 PNP inhibitor 71 Panzem R 71 histone deacetylase inhibitor 71 CYT# potent vascular disrupting 71 HQK 71 Guanilib 71 PKC# 71 PRTX 71 FOLOTYN ® 71 Hsp# Inhibitor 71 Aurora Kinase 71 volociximab 71 nicotinic alpha 7 71 receptor tyrosine kinase inhibitor 71 PLK1 SNALP 70 PARP inhibitor 70 hypoxia inducible factor 70 histone deacetylase HDAC inhibitor 70 MEK inhibitors 70 tyrosine kinase inhibitor 70 forodesine 70 humanized anti 70 IAP inhibitors 70 hormone LHRH antagonist 70 PEGylated Fab fragment 70 epothilone 70 AKT inhibitor 70 ENMD # 70 novel peptide 70 liposomal formulation 70 pertuzumab 70 vascular disrupting agent 70 luteinizing hormone releasing 70 erlotinib Tarceva ® 70 selective androgen receptor modulator 70 antibody MAb 70 sodium glucose cotransporter 70 PSN# [002] 70 TKM ApoB 70 humanized monoclonal 70 alpha folate receptor 70 FGFR 70 CORT # 70 OMP #M# 70 PI3K inhibitor 70 Sym# 70 Pathway Inhibitor 70 Phase Ib clinical trials 70 HCV protease 70 systemic RNAi therapeutic 70 CEQ# 70 YONDELIS 70 Elvitegravir 70 ARRY # 70 HDAC Inhibitor 70 PI3K/Akt pathway inhibitor 70 humanized monoclonal antibody 70 HGS# 70 Debio 70 selective immunoproteasome inhibitor 70 OXi# 70 Mipomersen 70 telomerase therapeutic 70 Cloretazine ® 70 Maribavir 70 Spiegelmer ® 70 INCB# [001] 70 JAK2 inhibitor 70 Ozarelix 69 Blinatumomab 69 EndoTAG TM -1 69 Dapagliflozin 69 HIV integrase inhibitor 69 mGluR5 negative 69 synthetic retinoid 69 rxRNA 69 HSP# inhibitor 69 ADP receptor antagonist 69 Phase IIa trials 69 highly selective inhibitor 69 Factor VIIa 69 nucleoside analog 69 lexidronam injection 69 CDK inhibitor 69 huC# DM4 69 PEG SN# 69 Safinamide 69 phase IIb clinical 69 HGS ETR1 69 cathepsin K inhibitor 69 GW# [003] 69 Bortezomib 69 MT# MEDI 69 Tyrima 69 vascular disrupting agents 69 MAGE A3 ASCI 69 BAY #-# 69 TLR9 agonist 69 Sapacitabine 69 virus HCV protease inhibitor 69 IMA# 69 MGCD# [001] 69 glucagon receptor 69 gefitinib Iressa 69 NXL# 69 IMiDs R 69 reversible inhibitor 69 novel histone deacetylase 69 metaglidasen 69 EZN 69 Cetrorelix 69 vidofludimus 69 AQ4N 69 huN# DM1 69 Nanobody 69 signal transduction inhibitor 69 kinase inhibitor 69 Carfilzomib 69 selective inhibition 69 PXD# 69 renin inhibitor 69 vinca alkaloid 69 selective modulator 69 Onalta 69 immunomodulator 69 Kinase Inhibitor 69 Hedgehog pathway inhibitor 69 ganetespib 69 PHX# 69 gamma secretase inhibitor 68 Tarvacin TM 68 Pertuzumab 68 MTP inhibitor 68 fosbretabulin 68 lomitapide 68 siRNA therapeutic 68 multi kinase inhibitor 68 Aurora kinase inhibitor 68 dasatinib Sprycel 68 generation antisense 68 alvespimycin 68 selective kinase inhibitor 68 histone deacetylase HDAC inhibitors 68 Voreloxin 68 selectively inhibits 68 CBLC# 68 antisense oligonucleotide 68 anticancer agent 68 epothilones 68 AAG geldanamycin analog 68 RGB # 68 CK # novel 68 apoptosis proteins 68 antisense inhibitors 68 Aplidin 68 small molecule Hedgehog 68 Sudhir Agrawal D.Phil 68 Squalamine 68 Aviptadil 68 CD# antibody [001] 68 Dasatinib 68 Nexavar sorafenib 68 TACI Ig 68 therapeutic monoclonal antibodies 68 sodium thiosulfate STS 68 non nucleoside inhibitor 68 HCD# [002] 68 renin inhibitors 68 ISIS # 68 docetaxel Taxotere ® 68 CD# CEA 68 sorafenib tablets 68 dasatinib Sprycel ® 68 MORAb 68 TLK# 68 vaccine GRNVAC1 68 Romidepsin 68 2DG 68 TELINTRA 68 Traficet EN 68 elotuzumab 68 AVONEX ® 68 Cytochrome P# 68 ALN HPN 68 anti CD3 antibody 68 diarrhea predominant irritable 68 cMET 68 generation antisense inhibitor 68 BiTE antibody 68 Tezampanel 68 Phase #b/#a clinical 68 proteasome inhibitors 68 SPC# [001] 68 docetaxel Taxotere R 68 IMiDs ® 68 tiapamil 68 mTOR mammalian target 68 DNA RNA Medicines 68 selective antagonist 68 PRT# 68 Nanobody ® 68 Talabostat 68 reslizumab 68 polymerase inhibitors 68 Symadex 68 Cloretazine 68 nucleoside analogues 68 Annamycin 68 targeting CD# 68 Monoclonal Antibody 68 uricase 67 Tasimelteon 67 novel immunomodulatory 67 IL# PE#QQR 67 Tanespimycin 67 Vidofludimus 67 PEGylated anti 67 HCV polymerase inhibitors 67 beta 1a 67 Imprime PGG 67 small molecule tyrosine 67 VA# [002] 67 Ridaforolimus 67 Leukine ® 67 mGluR2 NAM 67 PDE4 67 CD3 monoclonal antibody 67 Recombinant Human 67 ALN TTR# 67 DB# [003] 67 pathophysiological effects 67 novel anticancer 67 VEGF receptor 67 acadesine 67 acyclovir Lauriad R 67 chimeric monoclonal antibody 67 CB2 selective receptor agonist 67 intravesical instillation 67 Dalbavancin 67 Cyclooxygenase Inhibiting Nitric Oxide 67 TBC# 67 Panzem 67 Tyrosine Kinase Inhibitor 67 TNF Tumor Necrosis Factor 67 CCR5 antagonist 67 Personalized Immunotherapy 67 cilengitide 67 non nucleoside HCV 67 depsipeptide 67 MET VEGFR2 67 cetuximab Erbitux R 67 Prodarsan ® 67 Protexia ® 67 eniluracil 67 LHRH antagonist 67 drug conjugate 67 selective androgen receptor modulators 67 Initiate Phase 67 thalidomide Thalomid 67 ATL# [002] 67 SinuNase ™ 67 selective inhibitor 67 cell lymphoma CTCL 67 novel VDA molecule 67 CD# monoclonal antibody 67 trastuzumab DM1 T DM1 67 PF # [001] 67 GLPG# 67 Janus Kinase 67 prostanoid 67 phase IIa clinical 67 bortezomib Velcade 67 obatoclax 67 small molecule glucokinase 67 Luteinizing Hormone Releasing Hormone 67 enzyme inhibitor 67 small molecule defensin 67 LY# [003] 67 dacetuzumab 67 TLR9 agonists 67 Immunotherapeutic 67 antisense inhibitor 67 Cannabinor 67 Phase Ib clinical 67 Solazed TM 67 chemically modified siRNA 67 Phase Ib study 67 PI3K/mTOR 67 siRNAs targeting 67 MT#/MEDI-# 67 angiogenesis inhibitor 67 KNS # 67 AP# [003] 67 Myocet 67 targeted antifolate 67 Nexavar ® 67 ErbB3 67 XL# XL# 67 PEGPH# 67 HGS ETR2 67 anti CD3 67 acetonide FA 67 Ceflatonin R 67 THR beta agonist 67 sodium Injection 67 EGFR HER2 67 Tesetaxel 67 Perifosine 67 teplizumab 67 Genasense ® oblimersen 67 Interferon alpha 67 Janus kinase 67 RAV# 67 GSK# [001] 67 HCV polymerase 67 preclinical efficacy 67 antisense drug 67 Degarelix 67 potently inhibit 67 Meets Primary Endpoint 67 Deforolimus 67 Zolinza 67 small molecule thrombopoietin 67 Azedra 67 visilizumab 67 Pradefovir 67 IgG1 monoclonal antibody 67 XmAb# 67 JAK inhibitors 67 Bicifadine 67 adenosine A2A 67 Plicera 67 Amrubicin 67 enzastaurin 67 R#/MEM 67 HuMax EGFr 67 RNAi Therapeutic 67 Elesclomol 67 Iloperidone 67 cutaneous T 67 Bendamustine 67 eprotirome 67 oral proteasome inhibitor 66 GRN#L 66 Phase 2b Clinical Trial 66 VitiGam 66 Pyridorin TM 66 OMP #R# 66 therapeutic monoclonal antibody 66 IgG1 antibody 66 familial amyloidotic polyneuropathy FAP 66 BXT # 66 Protein Kinase C 66 stable nucleic acid 66 isoform selective 66 Factor VEGF 66 Xyfid TM 66 Diamyd ® 66 FLT3 66 intranasal formulation 66 2 methoxyestradiol 66 YONDELIS R 66 humanised antibody 66 Ceflatonin 66 trastuzumab Herceptin R 66 polysaccharide polymer 66 ApoB SNALP 66 targeting PCSK9 66 INCB# [003] 66 Alocrest 66 ELACYT 66 partial agonist 66 nitric oxide donating prostaglandin 66 Histone Deacetylase 66 siRNA therapeutics 66 GPR# agonist 66 Elagolix 66 Hsp# inhibitor 66 CCR9 antagonist 66 Tumor Necrosis Factor 66 nucleotide analog 66 oncolytic 66 potent inhibitor 66 sulfonylhydrazine class 66 SUVN 66 receptor inhibitor 66 antagomirs 66 HDACi 66 reversible inhibitors 66 Posiphen 66 NOX E# 66 refractory chronic lymphocytic 66 Onalta ™ 66 Vicriviroc 66 orally bioavailable mimics 66 Enkephalin 66 RELOVAIR ™ 66 MGd 66 HCV polymerase inhibitor 66 AEGR 66 Factor Receptor 66 otelixizumab 66 Ixabepilone 66 S#P# 66 sphingosine 1 66 SCH # 66 CCR5 mAb 66 investigational pan BCR 66 Familial Adenomatous Polyposis FAP 66 HyperAcute 66 Fc fusion protein 66 Epratuzumab 66 oxidative stress inducer 66 Metastatic Melanoma 66 HDL Mimetic Peptide 66 PF # [002] 66 peptidic compound 66 Enzastaurin 66 Amplimexon 66 CR# vcMMAE 66 inhibitor RG# 66 Enzyme Replacement Therapy 66 poly ADP ribose polymerase 66 teduglutide 66 ThermoDox R 66 lintuzumab SGN 66 Epidermal Growth Factor Receptor 66 EOquin TM 66 thiazolides 66 M2 subunit 66 OncoVEX GM CSF 66 molecular imaging radiopharmaceutical 66 PLX# 66 Xanafide 66 Copegus ribavirin 66 Virulizin ® 66 Velcade bortezomib 66 Panzem R NCD 66 Aplidin R 66 Aganocide ® 66 GMX# 66 Kahalalide F 66 Prodarsan R 66 Junovan TM 66 generation purine nucleoside 66 ZEVALIN ® 66 registrational trial 66 JAK3 66 E2F 66 PD LID 66 microtubule inhibitor 66 corticosteroid dexamethasone 66 RNAi therapeutic targeting 66 preclinical compounds 66 alkylating agent 66 adecatumumab MT# 66 Golimumab 66 Pimavanserin 66 Curaxin CBLC# 66 Seliciclib 66 Darinaparsin 66 Phase 2a trial 66 HuLuc# 66 aurora kinase 66 LHRH 66 hypoxia selective 66 midstage trials 66 small molecule inhibitors 66 immune modulatory 66 small molecule 66 Temsirolimus 66 molecularly targeted 66 alefacept 66 systemically administered 66 exon skipping 66 immunotherapeutic vaccine 66 Tamibarotene 66 pomalidomide 66 Fx #A 66 Cimzia certolizumab pegol 66 AZD# 66 humanized antibody 66 Varespladib 66 GSK# [002] 66 Preclinical studies suggest 66 Rigel R# 66 Proxinium TM 66 BCR ABL inhibitor 66 Lixivaptan 66 Irinotecan 66 ASONEP 66 Angiocept 66 Bremelanotide 66 anti angiogenic agent 66 PEGylated 66 product platforms AZX# 66 entinostat 66 TKB# 66 LY# [002] 66 DEB# 66 REGN# 66 Vidaza azacitidine 66 Phase Ib 66 Pemetrexed 66 Zybrestat 66 Azacitidine 66 Phase Ib II 66 potent antiproliferative 66 PSN# [001] 66 metastatic colorectal 66 BRAF inhibitor 66 azoles 65 SARMs 65 HCV protease inhibitors 65 somatostatin analogue 65 RNA antagonists 65 Presents Preclinical Data 65 Chemokine Receptor 65 selective agonist 65 DXL# 65 DU #b 65 Androxal TM 65 cannabinor 65 CA4P 65 tubulin inhibitor 65 novel topoisomerase 65 Vandetanib 65 delta opioid receptor 65 apoptosis inducer 65 NPC 1C 65 receptor partial agonist 65 receptor agonist 65 anti CD3 monoclonal 65 Archexin 65 novel orally administered 65 RhuDex R 65 NEUGENE 65 XOMA 3AB 65 peripherally acting 65 MEK inhibitor RDEA# 65 BAL# [002] 65 NS5b 65 sodium glucose transporter 65 Abiraterone acetate 65 Thrombin 65 multicenter Phase II 65 Oral Insulin 65 BCR ABL inhibitors 65 c Raf kinase 65 targets Galectin receptors 65 Phase #b/#a trial 65 midstage clinical 65 highly selective endothelin 65 mTOR inhibitor 65 Parathyroid Hormone 65 Daclizumab 65 Vidaza R 65 TG# [003] 65 PNT# 65 Silodosin 65 Zorbtive TM 65 myelofibrosis polycythemia vera 65 Alzhemed TM 65 Exherin TM 65 Bruton tyrosine kinase 65 Intravenous Human 65 Ixempra 65 Receptor Agonist 65 IMiD 65 anticoagulant reversing agent 65 Omacetaxine mepesuccinate 65 apoptotic pathway 65 Tumour Vascular Disrupting Agent 65 RenaZorb TM 65 Myolimus 65 MEK Inhibitor 65 DPP4 inhibitor 65 Lenocta 65 oral antiviral 65 small molecule inhibitor 65 CIMZIA TM 65 PDX pralatrexate 65 deforolimus 65 IV Busulfex 65 Inhalation Solution 65 candidate deforolimus 65 mda 7 65 Campath ® 65 PrevOnco ™ 65 P2Y 65 Phase 2a Clinical Trial 65 ONCONASE R 65 rNAPc2 65 atacicept 65 JUVISTA R Human 65 evaluating tivozanib 65 octreotide implant 65 cinacalcet HCl 65 PCK# 65 histone deacetylase 65 allosteric modulator NAM 65 inhaled formulation 65 bevacizumab Avastin ® 65 Soliris eculizumab 65 anionic backbone 65 CCR2 65 Gleevec resistant 65 Civacir 65 GLYX 65 samarium Sm 65 receptor modulators 65 davunetide intranasal AL 65 Cethrin 65 VQD 65 mapatumumab 65 injectable formulation 65 lumiliximab 65 antidiabetic 65 oral anticancer 65 delivers fluocinolone acetonide FA 65 SGS# 65 transthyretin TTR mediated amyloidosis 65 EOquin 65 oncolytic virus therapy 65 modulator SERM 65 G Protein Coupled 65 ATL/TV# 65 immunomodulatory therapy 65 Nanobodies ® 65 accumulate preferentially 65 Cleviprex TM clevidipine 65 cetuximab Erbitux ® 65 Small Molecule 65 Phase 2b clinical trials 65 Akt inhibitor 65 5 HT6 receptor 65 preclinical 65 MyVax R 65 radiation sensitizer 65 Iluvien ® 65 Ophthotech 65 MAXY G# 65 A3 adenosine receptor 65 Glufosfamide 65 imatinib Gleevec ® 65 alpha#beta# integrin 65 Protexia R 65 Decitabine 65 platinum chemotherapeutic 65 sulodexide 65 GSK '# 65 HDAC inhibitor 65 agonist compounds 65 ceftazidime 65 2A receptor agonist 65 orally dosed 65 Amigal 65 maturation inhibitor 65 Phase 2a Trial 65 Phase IIIb clinical 65 MOR# 65 GRN# 65 PrevOnco 65 HIV integrase inhibitors 65 SGLT2 65 TRAIL receptor antibodies 65 Anticalin 65 PDE# 65 CRTH2 65 ospemifene 65 DGAT 65 urocortin 2 65 Linaclotide 65 CRF1 receptor antagonist 65 Aliskiren 65 melanocortin receptor agonists 65 RDEA# 65 Olaparib 65 etanercept Enbrel 65 TRAIL receptor 65 preclinically 65 Homspera TM 65 Crizotinib 65 insulin sensitizers 65 GRNVAC1 65 trastuzumab DM1 65 JVRS 65 Allovectin 7 R 65 immunomodulatory 65 bortezomib Velcade ® 65 generation Hsp# inhibitor 65 investigational hepatitis C 65 chemokine receptor 65 OncoVEX 65 WX UK1 65 TREANDA 65 leukemia AML 65 CYC# 65 Dacogen decitabine 65 Interferon gamma 65 Trastuzumab 65 Angiotensin Converting Enzyme 65 Anticalin R 65 potently inhibits 65 pitavastatin 65 interferon gamma 1b 65 Phase IIb Clinical Trial 65 ALS #-# 65 cyclin dependent kinase inhibitor 65 deCODE chemistry 65 Phenoptin 65 COX Inhibiting Nitric Oxide 65 TLR8 65 hormone LHRH 65 GLP toxicology studies 65 LymphoStat B TM 65 axitinib 65 RNA antagonist 65 compound PMX # 65 PS# [001] 65 generation nucleoside analog 65 LymphoStat B belimumab 65 cytostatic 65 IMC A# 65 sunitinib Sutent ® 65 specific lectin receptors 65 Combination REOLYSIN R 65 recombinant subunit vaccine 65 Receptors GPCRs 65 Azixa 65 AtuRNAi 65 soluble tumor necrosis 65 protein kinase inhibitors 65 PDE# inhibitors 65 humanized monoclonal antibodies 65 Agonist MABA program 65 dyskinesia PD LID 65 Pivotal Phase III 64 ocular formulation 64 tranilast 64 Gemzar ® 64 Fibroblast Growth Factor Receptor 64 p# MAP kinase inhibitor 64 colon carcinoma 64 HGS ETR1 mapatumumab 64 humanised monoclonal antibody 64 JAK#/JAK# 64 OvaRex R 64 multikinase inhibitor 64 Intravenous CP 64 Antiangiogenic 64 Liposomal 64 retapamulin 64 hyaluronidase enzyme 64 Phase #b/#a 64 MKC# MT 64 5 HT6 64 oral Hsp# inhibitor 64 Trofex 64 immune modulating 64 vivo validation 64 non nucleoside 64 ZK EPO 64 Trophos 64 NS#/#A protease 64 IND enabling 64 Solazed ™ 64 Onalta TM 64 #ME# 64 Cathepsin S 64 TLR7 64 Kinase Inhibitors 64 methylnaltrexone bromide 64 PTH analogue 64 Curaxin 64 nicotinic acetylcholine receptor 64 Behcet uveitis 64 vesicular monoamine transporter 64 thymalfasin 64 oral salmon calcitonin 64 Anavex #-# 64 VEGF Trap 64 AVE# 64 investigational HCV polymerase 64 histone deacetylase HDAC 64 E#F# 64 Aganocide R 64 Vascular Endothelial Growth 64 investigational monoclonal antibody 64 phase IIb study 64 Alfacell proprietary ribonuclease 64 immunotoxin 64 PRX# 64 topically administered 64 Insegia 64 EVIZON TM 64 T#I [002] 64 dihydrochloride 64 Zevalin R Ibritumomab 64 Microplasmin 64 XL# XL# XL# 64 investigational oral 64 PTP 1B 64 interleukin IL -# 64 gemcitabine Gemzar ® 64 Ampligen ® 64 Bevasiranib 64 Monoclonal antibody 64 Novel Oral 64 defensin mimetic antibiotic 64 5 HT2A serotonin 64 5 HT4 64 Cethrin R 64 PEGylated interferon 64 XL# inhibits 64 thymidylate synthase TS 64 flavopiridol 64 Spiegelmer 64 Antitumor activity 64 cyclin dependent kinases 64 tezampanel 64 P#X# 64 TYZEKA 64 intravesical infusion therapy 64 tumor xenograft models 64 Preclinical studies 64 ALN VSP 64 CUDC 64 XL# anticancer compounds 64 HCV NS5B polymerase 64 relapsed refractory multiple myeloma 64 pralatrexate injection folate analogue 64 PRX # 64 oral ghrelin agonist 64 ZOLINZA 64 Angiotensin 64 pharmacological chaperone 64 novel peptides 64 Zalypsis 64 IMiDs ® compound 64 ALK inhibitor 64 Etoposide 64 adult mesenchymal stem 64 irreversible inhibitor 64 evaluating satraplatin 64 GV# [001] 64 indibulin 64 phase Ib clinical 64 vorinostat 64 Locked Nucleic Acid LNA 64 Oncolytic 64 Granulocyte Colony Stimulating Factor 64 radezolid 64 Bavituximab 64 Zenvia ™ 64 Bezielle 64 radiolabeled 64 lead Aganocide compound 64 RG# ITMN 64 ara C 64 Survivin antagonist 64 Quark Biotech Inc. 64 intravenously administered 64 apoptosis inducers 64 Maxy G# 64 Randomized Phase 64 sorafenib Nexavar 64 Cx# [002] 64 ErbB 64 Methylnaltrexone 64 Selective Electrochemical Tumor Ablation 64 XmAb 64 BMS # 64 SYN# 64 potent topoisomerase II 64 Proellex TM 64 Imetelstat 64 HuMax CD4 64 CG# [003] 64 Solazed 64 synthetic siRNA 64 insulin sensitizer 64 myeloproliferative disorders 64 ON #.Na 64 Atrasentan 64 Shigamabs ® 64 KRN# 64 Chrysalin 64 Hedgehog Pathway Inhibitor 64 IMiDs 64 Platelet Derived Growth 64 IPL# 64 galiximab 64 Litx 64 Phase III Clinical Trial 64 MKC# MKC# PP 64 BiTE 64 SERMs 64 Davanat 64 investigational compound 64 nucleoside 64 superficial bladder cancer 64 Icatibant 64 CRx 64 castrate resistant prostate cancer 64 mu opioid receptor antagonist 64 oral Janus kinase 64 Apaziquone 64 Lisofylline LSF 64 XmAb ™ 64 ARRY 64 JAK2 Inhibitor 64 CD4 monoclonal antibody 64 benzimidazole 64 metastatic malignant 64 DermaVir Patch 64 RTP #i 64 IRX 2 64 CINOD 64 potent suppressor 64 trial evaluating PRX# 64 Vascular Disrupting Agent 64 dexpramipexole 64 induces apoptosis 64 CytoFabTM 64 TGR5 64 verteporfin 64 IFN α 64 oral nucleoside analogue 64 cancer immunotherapies 64 hypoxia activated prodrug 64 mGluR4 64 HCV nucleotide polymerase inhibitor 64 talabostat 64 DFMO 64 Octreotide 64 ISTODAX 64 Ecallantide 64 alagebrium 64 Epothilones 64 Phase IIb trials 64 JAK3 inhibitor 64 PREOS R 64 phase III isavuconazole 64 Tarmogen 64 receptor monoclonal antibody 64 EP #R 64 adenoviral 64 NFkB 64 Pharmos proprietary 64 siRNA binds 64 novel orally bioavailable 64 Antigen Specific 64 candidate CRLX# 64 anti fibrotic 64 JZP 64 SNT MC# 64 Phase IIb Trial 64 pan histone deacetylase 64 zanolimumab 64 long acting muscarinic 64 HDAC 64 brivanib 64 receptor blocker